|
Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
RECRUITINGPhase 3Sponsored by Hoffmann-La Roche
Actively Recruiting
PhasePhase 3
SponsorHoffmann-La Roche
Started2025-07-02
Est. completion2035-07-31
Eligibility
Age50 Years – 90 Years
Healthy vol.Accepted
Locations66 sites
View on ClinicalTrials.gov →
NCT07177352
Summary
This study is a pre-screening process used to assess participants' potential eligibility for Roche interventional Alzheimer's disease studies.
Eligibility
Age: 50 Years – 90 YearsHealthy volunteers accepted
Inclusion Criteria: \- Report of objective or subjective memory concerns (by the participant and/or their informant) within the last year with or without a previous clinical diagnosis of MCI or dementia due to AD. Exclusion Criteria: * Dependency in basic activities of daily living (bADLs) due to cognitive impairment * Visual or auditory impairment that would prevent them from performing the cognitive assessments (eyeglasses and hearing aids are permitted) * Any self-reported evidence or known diagnosis of a neurological or neurodegenerative condition that may lead to cognitive impairment other than AD * History of severe, clinically significant central nervous system trauma * Any serious medical condition that precludes a participant's safe participation and completion of a clinical study
Conditions2
Alzheimer's DiseaseAlzheimers Disease
Locations66 sites
Banner Alzheimer?s Institute
Phoenix, Arizona, 85006
Banner Sun Health Research Institute
Sun City, Arizona, 85351
Sun Valley Research Center, Inc.
Imperial, California, 92251
Inglewood Clinicals
Inglewood, California, 90301
Irvine Center for Clinical Research
Irvine, California, 92614
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
PhasePhase 3
SponsorHoffmann-La Roche
Started2025-07-02
Est. completion2035-07-31
Eligibility
Age50 Years – 90 Years
Healthy vol.Accepted
Locations66 sites
View on ClinicalTrials.gov →
NCT07177352